NDC 60492-0173-02 - CNJ-016
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60492-0173
- Requested NDC
- 60492-0173-02
- Package NDCs from labels
- 60492-0173-1, 60492-0173-2, 60492-0173-02
- Manufacturer
- Emergent BioSolutions Canada Inc.
- Effective date
- 2025-12-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CNJ-016 - Emergent BioSolutions Canada Inc. | Emergent BioSolutions Canada Inc. | 2025-12-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60492-0173-1 | CNJ-016 | 12 mL in 1 VIAL, SINGLE-USE | INJECTION | 12 | 8 | |
| 60492-0173-2 | CNJ-016 | 24 in 1 CARTON | INJECTION | 24 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60492-0173 | CNJ-016 (VACCINIA IMMUNE GLOBULIN (HUMAN)) INJECTION [EMERGENT BIOSOLUTIONS CANADA INC.] | 6 | Current NDC, Legacy NDC, 2 package rows | 20190522_a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60492-0173-1 | EA - Each | 60492-0173 | 5bb3db26-44c1-4a96-969a-13a4598ec23c | 1 | 2022-10-06 |
| 60492-0173-2 | EA - Each | 60492-0173 | 1f78cef1-05ba-4df4-aa26-904ca752adca | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-08-20 | Warnings | 6OZP39ZG8H |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | 6OZP39ZG8H |
| Rohto Cool Relief | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | dc8f1ff3-87ae-47ca-815f-5a0e34f8cf30 | 2026-06-19 | Warnings | 6OZP39ZG8H |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | 6OZP39ZG8H |
| CNJ-016 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | Emergent BioSolutions Canada Inc. | a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | BLA125109 60492-0173-1 60492-0173-2 60492-0173 60492017302 1922334 1922329 ad4abcf6-88ca-41ff-a0f0-75692c8d517c a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe 7UB4J759TD |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | 6OZP39ZG8H |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-15 | Warnings | 6OZP39ZG8H |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.